The global cotinine screening devices market size was valued at USD 499.73 million in 2024 and is estimated to hit around USD 798.63 million by 2034, growing at a CAGR of 4.8% from 2024 to 2034.
The cotinine screening devices market mainly focuses on the products that are used to detect cotinine in samples such as urine, saliva and blood. Cotinine is the biomarker of nicotine metabolism. These devices are used to assess tobacco use, healthcare diagnostics, insurance risk assessment, and various health campaigns. The market growth is driven by the rising awareness about the harmful effects of nicotine and the regulations on the use of smoking. These devices are in demand due to the various health campaigns on the topic of hazardous effect of smoking, which is causing market expansion.
The high cost of production and the low accuracy in testing are some of the challenges faced by players in the market. The cotinine screening devices market will grow in the future due to the technological advancement in the detection, reducing time for testing by using rapid testing kits and portable devices. The rising consumption of cigarettes and tobacco among the Asian and Pacific region and the workplace wellness programs due to this, the demand for the devices will rise in the future, leading to growth in the cotinine screening devices market.
Published by Ajit Bansod
